3291 related articles for article (PubMed ID: 7727726)
1. Antisense therapy of cancer.
Narayanan R
In Vivo; 1994; 8(5):787-93. PubMed ID: 7727726
[TBL] [Abstract][Full Text] [Related]
2. The NF-kappaB transcription factor in oncogenesis.
Sharma HW; Narayanan R
Anticancer Res; 1996; 16(2):589-96. PubMed ID: 8687102
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor decoy approach to decipher the role of NF-kappa B in oncogenesis.
Sharma HW; Perez JR; Higgins-Sochaski K; Hsiao R; Narayanan R
Anticancer Res; 1996; 16(1):61-9. PubMed ID: 8615671
[TBL] [Abstract][Full Text] [Related]
4. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
Carrasco D; Rizzo CA; Dorfman K; Bravo R
EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
[TBL] [Abstract][Full Text] [Related]
5. A DNA motif present in alpha V integrin promoter exhibits dual binding preference to distinct transcription factors.
Sharma HW; Higgins-Sochaski K; Perez JR; Narayanan R
Anticancer Res; 1995; 15(5B):1857-67. PubMed ID: 8572570
[TBL] [Abstract][Full Text] [Related]
6. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
Chavany C; Connell Y; Neckers L
Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
[TBL] [Abstract][Full Text] [Related]
7. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50.
Aoudjit F; Brochu N; Bélanger B; Stratowa C; Hiscott J; Audette M
Cell Growth Differ; 1997 Mar; 8(3):335-42. PubMed ID: 9056676
[TBL] [Abstract][Full Text] [Related]
8. Evidence for differential functions of the p50 and p65 subunits of NF-kappa B with a cell adhesion model.
Narayanan R; Higgins KA; Perez JR; Coleman TA; Rosen CA
Mol Cell Biol; 1993 Jun; 13(6):3802-10. PubMed ID: 8497281
[TBL] [Abstract][Full Text] [Related]
9. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Cogswell PC; Scheinman RI; Baldwin AS
J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
[TBL] [Abstract][Full Text] [Related]
10. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
Costello R; Cerdan C; Lipcey C; Algarté M; Martin Y; Baeuerle PA; Olive D; Imbert J
Cell Growth Differ; 1993 Nov; 4(11):947-54. PubMed ID: 7905283
[TBL] [Abstract][Full Text] [Related]
11. Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression.
Higgins KA; Perez JR; Coleman TA; Dorshkind K; McComas WA; Sarmiento UM; Rosen CA; Narayanan R
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9901-5. PubMed ID: 8234333
[TBL] [Abstract][Full Text] [Related]
12. Distinct nuclear factor-kappaB/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells.
Ishige K; Tanaka M; Arakawa M; Saito H; Ito Y
Neurochem Int; 2005 Dec; 47(8):545-55. PubMed ID: 16183169
[TBL] [Abstract][Full Text] [Related]
13. Two novel functions associated with the Rel oncoproteins: DNA replication and cell-specific transcriptional activation.
Ishikawa H; Asano M; Kanda T; Kumar S; Gélinas C; Ito Y
Oncogene; 1993 Nov; 8(11):2889-96. PubMed ID: 8414493
[TBL] [Abstract][Full Text] [Related]
14. Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B).
Dwarakanath RS; Sahar S; Reddy MA; Castanotto D; Rossi JJ; Natarajan R
J Mol Cell Cardiol; 2004 Apr; 36(4):585-95. PubMed ID: 15081318
[TBL] [Abstract][Full Text] [Related]
15. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
[TBL] [Abstract][Full Text] [Related]
16. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
[TBL] [Abstract][Full Text] [Related]
18. rel/NF-kappa B nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells.
Grumont RJ; Richardson IB; Gaff C; Gerondakis S
Cell Growth Differ; 1993 Sep; 4(9):731-43. PubMed ID: 8241021
[TBL] [Abstract][Full Text] [Related]
19. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter.
Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M
J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131
[TBL] [Abstract][Full Text] [Related]
20. Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B.
Costello R; Lipcey C; Algarté M; Cerdan C; Baeuerle PA; Olive D; Imbert J
Cell Growth Differ; 1993 Apr; 4(4):329-39. PubMed ID: 8098618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
